INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Pallas Capital Advisors LLC's Holding History (CIK: 0001862282)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 3,942 Value ($000) $520 Avg Close — Range —
Q4 2024
Shares 3,182 Value ($000) $266 Avg Close — Range —
Q3 2024
Shares 2,990 Value ($000) $226 Avg Close — Range —
Q2 2024
Shares 4,120 Value ($000) $309 Avg Close — Range —